Upadacitinib Earns FDA Approval for Ankylosing Spondylitis Upadacitinib Earns FDA Approval for Ankylosing Spondylitis

Janus kinase inhibitor offers oral option for patients who have failed treatment.FDA Approvals
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Rheumatology News Alert Source Type: news